Upcoming Events
There are no events scheduled at the moment, please check back soon.
Change Text Size:
Recent News
Peptimmune Presentation at the upcoming meeting of the American Society for Experimental NeuroTherapeutics
3/05/2010 – Dr. Zanelli will discuss the application of Peptimmune's DEEP technology to the development of a first-line disease modifying treatment for Parkinson's Disease.
Peptimmune Announces Second Grant of a United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis
3/05/2010 – CAMBRIDGE, Mass. - March 5, 2010. Peptimmune, Inc. a privately held biotechnology company, announced today the grant of US Patent Number 7,655,221 (the…
Peptimmune to Collaborate on Dengue Virus Vaccine and Point-of-Care Diagnostic with two DOD biomedical research facilities
9/24/2009 – Cambridge, Mass. Peptimmune, Inc. announced today that it has formed a research and development collaboration with the Walter Reed Army Institute of…
View more articles in the News Archives